PMID- 29580352
OWN - NLM
STAT- MEDLINE
DCOM- 20180404
LR  - 20221207
IS  - 1555-9823 (Electronic)
IS  - 0003-1348 (Linking)
VI  - 84
IP  - 2
DP  - 2018 Feb 1
TI  - Weight Loss and Glycemic Control after Sleeve Gastrectomy: Results from a Middle 
      Eastern Center of Excellence.
PG  - 238-243
AB  - Obesity and its associated metabolic disorders are strongly linked to both 
      morbidity and mortality. Sleeve gastrectomy (SG) has been established as an 
      effective means of weight loss for obese patients as well as a treatment for type 
      2 diabetes mellitus (T2DM). This study was designed to examine the short- and 
      midterm outcomes of patients who underwent SG in a Middle Eastern Center of 
      Excellence, a military training teaching hospital. The clinical outcomes of 59 
      patients with impaired glucose tolerance and T2DM who underwent SG between 2011 
      and 2014 with at least one and up to four years of follow-up were studied. Data 
      were collected and compared, including the pre- and post-surgery measures of 
      weight, body mass index, glycosylated hemoglobin (HbA1c), and fasting blood 
      glucose. Complete remission was defined as a fasting blood glucose level </=100 
      mg/dL, an HbA1c </=6 mg/dL, without use of antidiabetic medications. All patients 
      showed significant reduction in body mass index following SG. Tight glycemic 
      control was achieved among both diabetic and prediabetic patients. In this study, 
      88.14 per cent of all patients (diabetic and prediabetic) achieved complete 
      resolution from their impaired glucose tolerance and T2DM and maintained normal 
      blood glucose and HbA1C levels from one to four years postoperatively. SG is 
      beneficial both in terms of short- and midterm weight loss and glucose control in 
      both diabetic and prediabetic obese patients.
FAU - Al Khalifa, Khalid
AU  - Al Khalifa K
FAU - Al Ansari, Ahmed
AU  - Al Ansari A
FAU - Showaiter, May
AU  - Showaiter M
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Am Surg
JT  - The American surgeon
JID - 0370522
RN  - 0 (Biomarkers)
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Biomarkers/blood
MH  - Blood Glucose/*metabolism
MH  - Diabetes Mellitus, Type 2/blood/complications/*surgery
MH  - Female
MH  - Follow-Up Studies
MH  - *Gastrectomy/methods
MH  - Glycated Hemoglobin/metabolism
MH  - Humans
MH  - *Laparoscopy
MH  - Male
MH  - Middle Aged
MH  - Middle East
MH  - Obesity/complications/*surgery
MH  - Retrospective Studies
MH  - Treatment Outcome
MH  - *Weight Loss
MH  - Young Adult
EDAT- 2018/03/28 06:00
MHDA- 2018/04/05 06:00
CRDT- 2018/03/28 06:00
PHST- 2018/03/28 06:00 [entrez]
PHST- 2018/03/28 06:00 [pubmed]
PHST- 2018/04/05 06:00 [medline]
PST - ppublish
SO  - Am Surg. 2018 Feb 1;84(2):238-243.